JP6471302B2 - 細胞復元のための無細胞組成物及び同組成物の作成及び使用方法 - Google Patents

細胞復元のための無細胞組成物及び同組成物の作成及び使用方法 Download PDF

Info

Publication number
JP6471302B2
JP6471302B2 JP2016558732A JP2016558732A JP6471302B2 JP 6471302 B2 JP6471302 B2 JP 6471302B2 JP 2016558732 A JP2016558732 A JP 2016558732A JP 2016558732 A JP2016558732 A JP 2016558732A JP 6471302 B2 JP6471302 B2 JP 6471302B2
Authority
JP
Japan
Prior art keywords
cell
cell sample
subject
cells
receiver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016558732A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017510582A (ja
Inventor
グレコ，スティーヴ
シー．ギアンパパ ヴィンセント
シー．ギアンパパ ヴィンセント
Original Assignee
アドヴァンスド リジェン メディカル テクノロジーズ，エルエルシー
アドヴァンスド リジェン メディカル テクノロジーズ，エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/577,978 external-priority patent/US20150174166A1/en
Application filed by アドヴァンスド リジェン メディカル テクノロジーズ，エルエルシー, アドヴァンスド リジェン メディカル テクノロジーズ，エルエルシー filed Critical アドヴァンスド リジェン メディカル テクノロジーズ，エルエルシー
Publication of JP2017510582A publication Critical patent/JP2017510582A/ja
Priority to JP2018236137A priority Critical patent/JP6900358B2/ja
Application granted granted Critical
Publication of JP6471302B2 publication Critical patent/JP6471302B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2016558732A 2014-03-24 2015-03-24 細胞復元のための無細胞組成物及び同組成物の作成及び使用方法 Active JP6471302B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018236137A JP6900358B2 (ja) 2014-03-24 2018-12-18 細胞復元のための無細胞組成物及び同組成物の作成及び使用方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201461969694P 2014-03-24 2014-03-24
US61/969,694 2014-03-24
US14/577,978 US20150174166A1 (en) 2013-12-20 2014-12-19 Compositions for Cellular Restoration and Methods of Making and Using Same
US14/577,978 2014-12-19
PCT/US2014/071667 WO2015095794A1 (en) 2013-12-20 2014-12-19 Compositions for cellular restoration and methods of making and using same
USPCT/US2014/071667 2014-12-19
PCT/US2015/022285 WO2015148534A1 (en) 2014-03-24 2015-03-24 Cell free compositions for cellular restoration and methods of making and using same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018236137A Division JP6900358B2 (ja) 2014-03-24 2018-12-18 細胞復元のための無細胞組成物及び同組成物の作成及び使用方法

Publications (2)

Publication Number Publication Date
JP2017510582A JP2017510582A (ja) 2017-04-13
JP6471302B2 true JP6471302B2 (ja) 2019-02-20

Family

ID=54196315

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016558732A Active JP6471302B2 (ja) 2014-03-24 2015-03-24 細胞復元のための無細胞組成物及び同組成物の作成及び使用方法
JP2018236137A Active JP6900358B2 (ja) 2014-03-24 2018-12-18 細胞復元のための無細胞組成物及び同組成物の作成及び使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018236137A Active JP6900358B2 (ja) 2014-03-24 2018-12-18 細胞復元のための無細胞組成物及び同組成物の作成及び使用方法

Country Status (4)

Country Link
EP (2) EP4445915A3 (enExample)
JP (2) JP6471302B2 (enExample)
CR (1) CR20160495A (enExample)
WO (1) WO2015148534A1 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10772911B2 (en) 2013-12-20 2020-09-15 Advanced ReGen Medical Technologies, LLC Cell free compositions for cellular restoration and methods of making and using same
US11203754B2 (en) 2016-04-29 2021-12-21 Advanced ReGen Medical Technologies, LLC Microrna compositions and methods of making and using same
US11219643B2 (en) 2013-12-20 2022-01-11 Advanced ReGen Medical Technologies, LLC Compositions for cellular restoration and methods of making and using same
US11286463B2 (en) 2012-03-08 2022-03-29 Advanced ReGen Medical Technologies, LLC Reprogramming of aged adult stem cells

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10717981B2 (en) 2018-01-18 2020-07-21 Advanced ReGen Medical Technologies, LLC Therapeutic compositions and methods of making and using the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1766053A4 (en) * 2004-06-02 2007-12-12 Sourcepharm Inc MICROVESICLES CONTAINING RNA AND METHODS
WO2010150783A1 (ja) * 2009-06-25 2010-12-29 株式会社 日立メディコ 医用画像撮影装置
EP2363136A1 (en) * 2010-03-02 2011-09-07 Fresenius Medical Care Deutschland GmbH Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease
US20120093885A1 (en) * 2010-10-18 2012-04-19 Northwestern University Therapeutic vesicles
US8747915B1 (en) 2011-09-14 2014-06-10 Vincent C. Giampapa Dietary supplement system for multifunctional anti-aging management and method of use
WO2013066368A1 (en) * 2011-10-03 2013-05-10 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Use of mirna 126 to produce hematopoietic stem cells
US9427450B2 (en) * 2012-01-31 2016-08-30 Xon Cells, Inc. Therapeutic immune modulation by stem cell secreted exosomes
US9295696B2 (en) * 2012-06-08 2016-03-29 University of Pittsburgh—of the Commonwealth System of Higher Education Compositions and methods for restoring or rejuvenating stem/progenitor cell function
WO2014028493A2 (en) 2012-08-13 2014-02-20 Cedars-Sinai Medical Center Exosomes and micro-ribonucleic acids for tissue regeneration

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11286463B2 (en) 2012-03-08 2022-03-29 Advanced ReGen Medical Technologies, LLC Reprogramming of aged adult stem cells
US10772911B2 (en) 2013-12-20 2020-09-15 Advanced ReGen Medical Technologies, LLC Cell free compositions for cellular restoration and methods of making and using same
US11219643B2 (en) 2013-12-20 2022-01-11 Advanced ReGen Medical Technologies, LLC Compositions for cellular restoration and methods of making and using same
US11203754B2 (en) 2016-04-29 2021-12-21 Advanced ReGen Medical Technologies, LLC Microrna compositions and methods of making and using same

Also Published As

Publication number Publication date
EP4445915A2 (en) 2024-10-16
JP6900358B2 (ja) 2021-07-07
EP4445915A3 (en) 2025-01-22
JP2019052182A (ja) 2019-04-04
WO2015148534A1 (en) 2015-10-01
EP3122333A1 (en) 2017-02-01
CR20160495A (es) 2017-05-29
EP3122333A4 (en) 2017-11-29
JP2017510582A (ja) 2017-04-13

Similar Documents

Publication Publication Date Title
JP6353073B2 (ja) 細胞回復のための組成物並びにその作製及び使用方法
JP7343549B2 (ja) マイクロｒｎａ組成物並びにその作製及び使用方法
JP6900358B2 (ja) 細胞復元のための無細胞組成物及び同組成物の作成及び使用方法
US10772911B2 (en) Cell free compositions for cellular restoration and methods of making and using same
Xing et al. Emerging role of exosomes in craniofacial and dental applications
KR20190084207A (ko) 지방 조직 유래의 중간엽 기질 세포 조정 배지 및 이것의 제조 및 사용 방법
JP2007535486A (ja) 高分子量のヒアルロン酸を用いた内因性又は埋め込まれた又は移植された幹細胞の機能回復を促進するための方法
US20230174939A1 (en) Novel anucleated cells as a source for treatment of platelet rich plasma dependent disorders
KR20170139701A (ko) 세포 회복을 위한 조성물 및 그의 제조 및 사용 방법
CA3130698A1 (en) Methods and clinical protocols and kits pertaining to making and using therapeutic compositions for cellular treatment
WO2023227087A1 (en) Plectranthus amboinicus extract for use in inhibiting immune responses
CN109674972A (zh) 月桃精油的应用
AU2024206401A1 (en) Megakaryocyte derivatives for treatment of dry eye diseases
CN116615210A (zh) 新型无核细胞作为来源用于治疗富血小板血浆依赖性病症
US20130053449A1 (en) Method for inhibiting histone gene transcription and expression

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161101

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171024

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180119

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180424

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180717

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20181120

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20181214

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20181217

R150 Certificate of patent or registration of utility model

Ref document number: 6471302

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250